The Palm Beach Gardens, Florida-based company said the new appointments provide a strategic enhancement and align with its mission. Accelus aims to deliver innovative spinal solutions that elevate the surgical experience and improve patient outcomes. It raised $20 million to support that expandable spine implant technology just last month.
McGann currently serves as president and CEO at Accelus, a role he first took up in April 2023. He originally joined the company in 2019 and served in roles including the post of chief commercial officer. McGann brings extensive experience in the spine industry, with previous positions including the role of VP of sales at Stryker.
Additionally, McGann served as VP of U.S. sales for Medtronic Spine & Biologics and area director of sales for Kyphon (now part of Medtronic). He also served as president of Lumenis and regional sales director for U.S. Surgical.
Haffey, the founder of Haffey & Co., has more than 20 years of experience utilizing the high-performance management system (HPMS) framework with a proven track record in executive management and leadership. He served as president and CEO of two venture-backed startups, Nexis Vision and NDO Surgical. Both achieved structured exits under his leadership.
Other roles included EVP and chief commercial officer posts at both Summit Technology and IntraLase Corp.
Accelus believes that its strong leadership team can help with its efforts toward both global and U.S. expansion. The company’s Adaptive Geometry technology features a unique design demonstrating favorable fusion and patient outcomes in clinical reports. Its FlareHawk interbody fusion system, in particular, can conform to patients’ endplate geometry, the company says.
“I am delighted by the addition of Kevin McGann and Bernie Haffey to the Accelus board of directors,” said Alex Lukianov, chair of the board for Accelus. “Their seasoned leadership and depth of expertise will be instrumental to becoming the global market leader in expandable spinal implants as we strive to refine and advance procedures for superior patient outcomes.”